RYTM Rhythm Pharmaceuticals, Inc.
$104.71▲ +2.46%
Healthcare
Other
After hours
$104.71▲ +0.00%
Sep 11, 7:30 PM ET
Volume 573.7K
Avg Volume (10D) 446.6K
Key Metrics & Fundamentals
Market Cap
$7.21B
P/E Ratio
–
Div Yield
–%
52W Range
74.50 - 122.20
% vs 50 MA
-3.83%
% vs 200 MA
5.12%
RSI-14
44.7
MACD Histogram
-0.8900
Beta (1Y vs SPY)
0.99
Free Cash Flow
-$9.15M
Gross Rev
$71.26M
Gross Profit
$62.32M
EBITDA
-$44.06M
COGS
$8.93M
Operating Exp
$110.88M
Operating Income
-$48.55M
EBIT
-$48.55M
Pretax Income
-$48.85M
Net Income
-$49.30M
EPS (Diluted)
-0.73
Price & Volume History
Loading chart…
Recent News
Billionaire Stanley Druckenmiller’s 2 New Healthcare Stock Picks
Insider Monkey · Sep 11, 2026 12:47 PM
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
GlobeNewswire · Sep 10, 2026 12:00 PM
An AI drug specialist zeroes in on rare forms of obesity
BioPharma Dive · Sep 3, 2026 12:20 PM
Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls
The Fly · Aug 28, 2026 1:38 PM
Here Are Friday’s Top Wall Street Analyst Research Calls: Baozun, Commerce Bancshares, Element Solutions, Evolution Petroleum, Petrobras, Rythm Pharmaceuticals, Terawulf, UMB Financial, Workday, and More
24/7 Wall St. · Aug 28, 2026 11:50 AM
Deutsche Bank Initiates Rhythm Pharmaceuticals at Hold With $120 Price Target
MT Newswires · Aug 28, 2026 11:26 AM
Rhythm Pharmaceuticals (RYTM) Stock Looks Overvalued Despite Its 7x Five Year Run
Simply Wall St. · Aug 26, 2026 10:15 AM
Rhythm Pharmaceuticals Receives Japan Approval for Imcivree
MT Newswires · Aug 24, 2026 12:43 PM
Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
GlobeNewswire · Aug 24, 2026 12:00 PM
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can
Motley Fool · Aug 23, 2026 10:20 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See RYTM's money flow as a full page
Social Sentiment
No Reddit posts found for RYTM.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.